{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:13:20Z","timestamp":1789913600960,"version":"4.0.1"},"reference-count":73,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T00:00:00Z","timestamp":1554768000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.00724","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T06:44:09Z","timestamp":1554792249000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["The F1F3 Recombinant Chimera of Leishmania donovani-Nucleoside Hydrolase (NH36) and Its Epitopes Induce Cross-Protection Against Leishmania (V.) braziliensis Infection in Mice"],"prefix":"10.3389","volume":"10","author":[{"given":"Marcus Vin\u00edcius","family":"Alves-Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirlei","family":"Nico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Melo","family":"de Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisa B.","family":"Palatnik de-Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,4,9]]},"reference":[{"key":"B1","unstructured":"WHO Leishmaniasis\u2013Clinical Forms Leishmaniases.2018"},{"key":"B2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fcimb.2012.00059","article-title":"The influence of early neutrophil-Leishmania interactions on the host immune response to infection","volume":"2","author":"Ribeiro-Gomes","year":"2012","journal-title":"Front Cell Infect Microbiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e0003742","DOI":"10.1371\/journal.pntd.0003742","article-title":"Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis","volume":"9","author":"Baharia","year":"2015","journal-title":"PLoSNegl Trop Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e980","DOI":"10.1371\/journal.pntd.0000980","article-title":"Mucosal Leishmaniasis Caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensisin the Brazilian Amazon","volume":"5","author":"Guerra","year":"2011","journal-title":"PLoSNegl Trop Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/1471-2334-13-529","article-title":"Immunologic response and memory T cells in subjects cured of tegumentar leishmaniasis","volume":"13","author":"Carvalho","year":"2013","journal-title":"BMC Infect Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cyto.2013.12.016","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis","volume":"66","author":"Oliveira","year":"2014","journal-title":"Cytokine."},{"key":"B7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/qjmed\/hct116","article-title":"Leishmaniasis: clinical syndromes and treatment","volume":"107","author":"McGwire","year":"2014","journal-title":"QJM."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e0005100","DOI":"10.1371\/journal.pntd.0005100","article-title":"Atypical manifestations of cutaneous leishmaniasis in a region endemic for Leishmania braziliensis: clinical, immunological and parasitological aspects","volume":"10","author":"Guimaraes","year":"2016","journal-title":"PLosNegl Trop Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/j.1469-0691.2011.03640.x","article-title":"Clinical pleiomorphism in human leishmaniases, with special mention of asymptomatic infection","volume":"17","author":"Ba\u00f1uls","year":"2011","journal-title":"ClinMicrobiol Infect."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6734","DOI":"10.1128\/IAI.70.12.6734-6740.2002","article-title":"Up-regulation of Th1- type responses in mucosal leishmaniasis patients","volume":"70","author":"Bacellar","year":"2002","journal-title":"Infect Immun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.imlet.2005.06.004","article-title":"Activated inflammatory T cells correlate with lesion size in human cutaneous leishmaniasis","volume":"101","author":"Antonelli","year":"2005","journal-title":"Immunol Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6473","DOI":"10.4049\/jimmunol.181.9.6473","article-title":"Functional dichotomy of dendritic cells following interaction with Leishmania braziliensis: infected cells produce high levels of TNF-\u03b1, whereas bystander dendritic cells are activated to promote T cell responses","volume":"181","author":"Carvalho","year":"2008","journal-title":"J Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1128\/IAI.02404-14","article-title":"Protective and pathological functions of CD8+ T cells in Leishmania braziliensis infection","volume":"83","author":"Cardoso","year":"2014","journal-title":"Infect Immun."},{"key":"B14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1590\/S0074-02762013000100003","article-title":"Inflammation in disseminated lesions: an analysis of CD4+, CD20+, CD68+, CD31+ and vW+ cells in non-ulcerated lesions of disseminated leishmaniasis","volume":"108","author":"Mendes","year":"2013","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00281-012-0350-8","article-title":"Immunopathogenesis of non-healing American cutaneous leishmaniasis and progressive visceral leishmaniasis","volume":"34","author":"Soong","year":"2012","journal-title":"SeminImmunopathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1590\/S0074-02761991000100009","article-title":"Evaluation of the histopathological classifications of american cutaneous and mucocutaneous leishmaniasis","volume":"86","author":"Bittencourt","year":"1991","journal-title":"Men Inst Oswaldo Cruz."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1016\/j.micinf.2007.04.009","article-title":"IL-10 producing CD8+ T cells in human infection with Leishmania guyanensis","volume":"9","author":"Bourreau","year":"2007","journal-title":"Microbes Infect."},{"key":"B18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/pim.12109","article-title":"Leishmania braziliensis amastigotes stimulate production of IL-1\u03b2, IL-6, IL-10 and TGF- \u03b2 by peripheral blood mononuclear cells from nonendemic area healthy residents","volume":"36","author":"Gomes","year":"2014","journal-title":"Parasite Immunol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3389\/fimmu.2013.00156","article-title":"Interferon gamma in Leishmaniasis","volume":"4","author":"Kima","year":"2013","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e845","DOI":"10.1371\/journal.pntd.0000845","article-title":"CD8+ T cells as a source of IFN-\u03b3 production in human cutaneous leishmaniasis","volume":"4","author":"Nateghi","year":"2010","journal-title":"PLosNegl Trop Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"ClinMicrobiol Rev."},{"key":"B22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.actatropica.2013.02.002","article-title":"Assessment of drug resistance related genes as candidate markers for treatment outcome prediction of cutaneous leishmaniasis in Brazil","volume":"126","author":"Torres","year":"2013","journal-title":"Acta Trop."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e2871","DOI":"10.1371\/journal.pntd.0002871","article-title":"Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia","volume":"8","author":"Fern\u00e1ndez","year":"2014","journal-title":"PLosNegl Trop Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4269\/ajtmh.1996.55.125","article-title":"The logic of visceral leishmaniasis control","volume":"55","author":"Dye","year":"1996","journal-title":"Am J Trop Med Hyg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.imbio.2016.09.015","article-title":"A vaccine composed af a hypothetical protein and the eukaryotic initiation factor 5a from Leishmania braziliensis cross-protection against Leishmania amazonensis infection","volume":"222","author":"Duarte","year":"2017","journal-title":"Immunobiology."},{"key":"B26","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0035-9203(00)90239-6","article-title":"Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniaisis in Colombia: a randomised controlled trial","volume":"94","author":"V\u00e9lez","year":"2000","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1080\/00034983.1995.11813017","article-title":"Vaccines against leishmaniasis","volume":"89","author":"Modabber","year":"1995","journal-title":"Ann Trop Med Parasitol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years","volume":"26","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine."},{"key":"B29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3389\/fimmu.2016.00151","article-title":"Cutaneous leishmaniasis vaccination: a matter of quality","volume":"7","author":"De Luca","year":"2016","journal-title":"Front Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4991","DOI":"10.1016\/j.vaccine.2008.07.029","article-title":"Immunogenicity assay of the Leishmune\u00ae vaccine against canine visceral leishmaniasis in Brazil","volume":"26","author":"Borja-Cabrera","year":"2008","journal-title":"Vaccine."},{"key":"B31","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1016\/j.vaccine.2009.03.045","article-title":"Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune\u00ae in Brazilian endemic areas","volume":"27","author":"Palatnik-de-Sousa","year":"2009","journal-title":"Vaccine."},{"key":"B32","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1586\/14760584.7.6.833","article-title":"2008. The FML-vaccine against canine visceral leishmaniasis: from the second generation to the synthetic vaccine","volume":"7","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Expert Rev Vaccines."},{"key":"B33","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1128\/IAI.73.2.812-819.2005","article-title":"Cross-protective efficacy of a prophylactic Leishmania Donovan DNA vaccine against visceral and cutaneous murine leishmaniasis","volume":"73","author":"Aguilar-Be","year":"2005","journal-title":"Infect Immun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0378-1119(01)00768-5","article-title":"A nonspecific nucleoside hydrolase from Leishmania Donovan: implications for purine salvage by the parasite","volume":"280","author":"Cui","year":"2001","journal-title":"Gene."},{"key":"B35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3389\/fimmu.2014.00189","article-title":"Cross-protective immunity to Leishmania amazonensis is mediated by CD4+ and CD8+ epitopes of Leishmania Donovan nucleoside hydrolase terminal domains","volume":"5","author":"Nico","year":"2014","journal-title":"Front Immun."},{"key":"B36","unstructured":"29354373Blast-Basic Local Alignment Search Tool.2016"},{"key":"B37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3389\/fimmu.2014.00273","article-title":"Leishmania Donovan nucleoside hydrolase terminal domains in cross-protective immunotherapy against Leishmania amazonensis murine infection","volume":"5","author":"Nico","year":"2014","journal-title":"Front Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e866","DOI":"10.1371\/journal.pntd.0000866","article-title":"Adaptive immunity against Leishmania nucleoside hydrolase maps its C-terminal domain as the target of the CD4+ T cell\u2013driven protective response","volume":"4","author":"Nico","year":"2010","journal-title":"PLos Negl Trop Dis."},{"key":"B39","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fimmu.2017.00100","article-title":"A chimera containing CD4+ and CD8+ T-cell epitopes of the Leishmania Donovan nucleoside hydrolase NH36 optimizes cross-protection against Leishmania amazonesis infection","volume":"8","author":"Alves-Silva","year":"2017","journal-title":"Front Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-Cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fimmu.2017.00227","article-title":"Leishmania Donovan Nucleoside Hydrolase (NH36) domains induce T-cell cytokine responses in human visceral leishmaniasis","author":"Barbosa Santos","year":"2017","journal-title":"Front Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"9375","DOI":"10.1073\/pnas.0703678104","article-title":"Evolutionary and geographical history of Leishmania Donovan complex with a revision of current taxonomy","volume":"104","author":"Lukes","year":"2007","journal-title":"Proc Natl Acad Sci USA."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e0124183","DOI":"10.1371\/journal.pone.0124183","article-title":"Immucillins impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis multiplication in vitro","volume":"10","author":"Freitas","year":"2015","journal-title":"PLoS ONE."},{"key":"B44","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pep.2016.10.008","article-title":"Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania Donovan, a vaccine candidate for preventing cutaneous leishmaniasis","volume":"130","author":"McAtee","year":"2017","journal-title":"Protein Expr Purif."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.4269\/ajtmh.2007.77.1060","article-title":"Protection of susceptible BALB\/c mice from challenge with Leishmania major by nucleoside hydrolase, a soluble exo-antigen of Leishmania","volume":"77","author":"Al-Wabel","year":"2007","journal-title":"Am J Trop Med Hyg."},{"key":"B46","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3389\/fimmu.2018.00967","article-title":"Nh36 and F3 antigen-primed dendritic cells show preserved migrationg capabilities and CCR7 expression and F3 is effective in immunotherapy of visceral leishmaniasis","volume":"9","author":"Nico","year":"2018","journal-title":"Front Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE","volume":"4","author":"Coler","year":"2015","journal-title":"Clin Transl Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/eji.1830250329","article-title":"Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo","volume":"25","author":"Germann","year":"1995","journal-title":"Eur J Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/eji.1830111212","article-title":"Activation of mouse complement by monoclonal mouse antibodies","volume":"11","author":"Neuberger","year":"1981","journal-title":"Eur J Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/0167-5699(92)90120-V","article-title":"Intermolecular cooperativity: a clue to why mice have IgG3?","volume":"13","author":"Greenspan","year":"1992","journal-title":"Immunol Today."},{"key":"B51","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/294088a0","article-title":"Mouse IgG3 antibodies are highly protective against infection with Streptococcus pneumoniae","volume":"294","author":"Briles","year":"1981","journal-title":"Nature."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e1622","DOI":"10.1371\/journal.pntd.0001622","article-title":"Improved canine and human visceral leishmaniasis immunodiagnosis using combinations of synthetic peptides in enzyme-linked immunosorbent assay","volume":"6","author":"Costa","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"B53","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.4049\/jimmunol.135.6.4144","article-title":"Cell mediated immunity in American cutaneous and mucosal leishmaniasis","volume":"135","author":"Carvalho","year":"1985","journal-title":"J Immunol."},{"key":"B54","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1590\/S0074-02762007005000069","article-title":"T-cell responses associated with resistance to Leishmania infection in individuals from endemic areas for Leishmania (Viannia) braziliensis","volume":"102","author":"Bittar","year":"2007","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B55","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1590\/S0036-46652014000500002","article-title":"Montenegro skin test and age of skin lesion as predictors of treatment failure in cutaneous leishmaniasis","volume":"5695","author":"Antonio","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e1947","DOI":"10.1371\/journal.pntd.0001947","article-title":"IFN-\u03b3 production to leishmania antigen supplements the leishmania skin test in identifying exposure to L. braziliensis infection","volume":"6","author":"Schnorr","year":"2012","journal-title":"PLoS Negl Trop Dis."},{"key":"B57","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/j.1365-3024.2009.01116.x","article-title":"Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis","volume":"31","author":"Silveira","year":"2009","journal-title":"Parasite Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/ije\/15.4.572","article-title":"Controlled field trials of a vaccine against new world cutaneous leishmaniasis","volume":"15","author":"Antunes","year":"1986","journal-title":"Int J Epidemiol."},{"key":"B59","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0035-9203(79)90159-7","article-title":"A field trial of a vaccine against American dermal leishmaniasis","volume":"73","author":"Mayrink","year":"1979","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"B60","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1590\/S0074-02762010000100013","article-title":"Comparative evaluation of phenol and thimerosal as preservatives for a candidate vaccine against American cutaneous leishmaniasis","volume":"105","author":"Mayrink","year":"2010","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"B61","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1365-3024.2007.00940.x","article-title":"Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as a model for pathogenesis","volume":"29","author":"Carvalho","year":"2007","journal-title":"Parasite Immunol."},{"key":"B62","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1365-3024.2007.00940.x","article-title":"Differential immune regulation of activated T cells between cutaneous and mucosal leishmaniasis as model for pathogenesis","volume":"29","author":"Carvalho","year":"2007","journal-title":"Parasite Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3389\/fimmu.2016.00327","article-title":"Combination of in silico methods in the search for potential CD4(+) and CD8(+) T cell epitopes in the proteome of Leishmania braziliensis","volume":"7","author":"Silva R de","year":"2016","journal-title":"Front Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00281-015-0475-7","article-title":"CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly","volume":"37","author":"Novais","year":"2015","journal-title":"Semin Immunopathol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"969","DOI":"10.4049\/jimmunol.165.2.969","article-title":"A natural model of Leishmania major infection reveals a prolonged \u201csilent\u201d phase of parasite amplification in the skin before the onset of lesion formation and immunity","volume":"165","author":"Belkaid","year":"2000","journal-title":"J Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4269\/ajtmh.2008.78.122","article-title":"A real-time polymerase chain reaction assay for the identification and quantification of American Leishmania species on the basis of glucose-6-phosphate dehydrogenase","volume":"78","author":"Castilho","year":"2008","journal-title":"Am J Trop Med Hyg."},{"key":"B68","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.molimm.2016.06.014","article-title":"A vaccine combining two Leishmania braziliensis proteins offers heterologous protection against Leishmania infantum infection","volume":"76","author":"Duarte","year":"2016","journal-title":"Mol Immunol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1017\/S0031182012002156","article-title":"Golden hamster (Mesocricetus auratus) as an experimental model for Leishmania (Viannia) braziliensis infection","volume":"140","author":"Gomes-Silva","year":"2013","journal-title":"Parasitology."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e0003889","DOI":"10.1371\/journal.pntd.0003889","article-title":"A review: the current in vivo models for the discovery and utility of new anti-leishmanial drugs targeting cutaneous leishmaniasis","volume":"9","author":"Mears","year":"2015","journal-title":"PLoS Negl Trop Dis."},{"key":"B71","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.vetimm.2011.05.002","article-title":"In situ characterization of the granulomatous immune response with time in nonhealing lesional skin of Leishmania braziliensis infected rhesus macaques (Macaca mulatta)","volume":"142","author":"Souza-Lemos","year":"2011","journal-title":"Vet Immunol Immunopathol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.vetimm.2010.04.009","article-title":"Systemic and compartmentalized immune responses in a Leishmania braziliensis-macaque model of self-healing cutaneous leishmaniasis","volume":"137","author":"de-Campos","year":"2010","journal-title":"Vet Immunol Immunopathol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"5827","DOI":"10.1128\/IAI.73.9.5827-5834.2005","article-title":"Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis","volume":"73","author":"de Moura","year":"2005","journal-title":"Infect Immun."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00724\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T14:38:24Z","timestamp":1694788704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.00724\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,9]]},"references-count":73,"alternative-id":["10.3389\/fimmu.2019.00724"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.00724","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,9]]},"article-number":"724"}}